US Patent Issued to Loma Linda University Health on Dec. 2 for "Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease" (California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,538, issued on Dec. 2, was assigned to Loma Linda University Health (Loma Linda, Calif.).

"Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease" was invented by Salvador Soriano (Loma Linda, Calif.) and Michael Castello (Loma Linda, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, methods of diagnosing a subject as having Alzheimer's disease and prognosing a subject as being at risk of progressing to Alzheimer's disease are provided. In some embodiments, the method comprises determining one or more of the level of expression of rhotekin 2 (RTKN2), the level of expression of microtubule-associate...